Edward C. Saltzman's Insider Trades & SAST Disclosures

Edward C. Saltzman's most recent trade in Nurix Therapeutics Inc was a trade of 25,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on May 19, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Nurix Therapeutics Inc
Edward C. Saltzman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2025 25,000 25,000 - - Director Stock Option (right to buy)
Nurix Therapeutics Inc
Edward C. Saltzman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2024 25,000 25,000 - - Director Stock Option (right to buy)
Nurix Therapeutics Inc
Edward C. Saltzman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 May 2023 25,000 25,000 - - Director Stock Option (right to buy)
Nurix Therapeutics Inc
Edward C. Saltzman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2022 50,000 50,000 - - Director Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades